HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $430,166 | +4.8% | 4,802 | -0.4% | 0.00% | 0.0% |
| Q2 2023 | $410,373 | +1.4% | 4,820 | -1.5% | 0.00% | 0.0% |
| Q1 2023 | $404,736 | +7.8% | 4,891 | +2.5% | 0.00% | 0.0% |
| Q4 2022 | $375,320 | +3.7% | 4,772 | -2.4% | 0.00% | 0.0% |
| Q3 2022 | $362,000 | -21.0% | 4,887 | -30.4% | 0.00% | 0.0% |
| Q2 2022 | $458,000 | -20.3% | 7,025 | -22.8% | 0.00% | 0.0% |
| Q1 2022 | $575,000 | +20.5% | 9,096 | +1.1% | 0.00% | 0.0% |
| Q4 2021 | $477,000 | -47.2% | 8,995 | -29.8% | 0.00% | 0.0% |
| Q3 2021 | $904,000 | -46.9% | 12,810 | -49.8% | 0.00% | -66.7% |
| Q2 2021 | $1,701,000 | -28.5% | 25,516 | +19.0% | 0.00% | -25.0% |
| Q1 2021 | $2,380,000 | -6.1% | 21,434 | +0.4% | 0.00% | -20.0% |
| Q4 2020 | $2,535,000 | +43.1% | 21,352 | +5.1% | 0.01% | +25.0% |
| Q3 2020 | $1,772,000 | +170.5% | 20,308 | +177.8% | 0.00% | +100.0% |
| Q2 2020 | $655,000 | +50.9% | 7,311 | +68.4% | 0.00% | +100.0% |
| Q1 2020 | $434,000 | -45.3% | 4,341 | -37.5% | 0.00% | -50.0% |
| Q4 2019 | $793,000 | -17.7% | 6,944 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $964,000 | +159.8% | 7,605 | +146.6% | 0.00% | +100.0% |
| Q2 2019 | $371,000 | -42.5% | 3,084 | -58.4% | 0.00% | -50.0% |
| Q1 2019 | $645,000 | -25.2% | 7,406 | -13.4% | 0.00% | -33.3% |
| Q4 2018 | $862,000 | +116.0% | 8,550 | +145.7% | 0.00% | +200.0% |
| Q3 2018 | $399,000 | -65.2% | 3,480 | -72.8% | 0.00% | -75.0% |
| Q2 2018 | $1,145,000 | +23.3% | 12,780 | +1.0% | 0.00% | +33.3% |
| Q1 2018 | $929,000 | +26.9% | 12,657 | +0.3% | 0.00% | +50.0% |
| Q4 2017 | $732,000 | +27.5% | 12,614 | -1.4% | 0.00% | 0.0% |
| Q3 2017 | $574,000 | +22.1% | 12,791 | +7.3% | 0.00% | 0.0% |
| Q2 2017 | $470,000 | +25.0% | 11,924 | +28.9% | 0.00% | +100.0% |
| Q1 2017 | $376,000 | +1.1% | 9,249 | -0.5% | 0.00% | -50.0% |
| Q4 2016 | $372,000 | -18.6% | 9,297 | -26.2% | 0.00% | 0.0% |
| Q3 2016 | $457,000 | -6.0% | 12,596 | -24.8% | 0.00% | 0.0% |
| Q2 2016 | $486,000 | -21.0% | 16,748 | -4.9% | 0.00% | -33.3% |
| Q1 2016 | $615,000 | +5.5% | 17,605 | -2.8% | 0.00% | 0.0% |
| Q4 2015 | $583,000 | +2.8% | 18,108 | +3.4% | 0.00% | 0.0% |
| Q3 2015 | $567,000 | -58.7% | 17,513 | -47.1% | 0.00% | -25.0% |
| Q2 2015 | $1,372,000 | +114.7% | 33,110 | +133.0% | 0.00% | +33.3% |
| Q1 2015 | $639,000 | +138.4% | 14,213 | +98.6% | 0.00% | +200.0% |
| Q4 2014 | $268,000 | +4.7% | 7,158 | -2.4% | 0.00% | -50.0% |
| Q3 2014 | $256,000 | – | 7,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |